Intralesional bleomycin sulfate injection for the treatment of verruca plantaris

Journal of the American Podiatric Medical Association

Volumn 96, Issue 3, 2006, Pages 220-225

  Salk, Robert ^a,c   Douglas, Troy S ^b  

^a Northern California Foot and Ankle Center   (United States)

^b ST MARY S MEDICAL CENTER   (United States)

^c Northern California Foot and Ankle Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745097979     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/0960220     Document Type: Article

References (37)

1. GLOVER MG: Plantar warts. Foot Ankle 11: 172, 1990.
2. MASSING AM, EPSTEIN WL: Natural history of warts. Arch Dermatol 87: 306, 1963.
3. PENNEYS N: "Diseases Caused by Viruses," in Lever's Histopathology of the Skin, 8th Ed, ed by D Elder, R Elenitasas, C Jaworsky, et al, p 578, Lippincott-Raven, Philadelphia, 1997.
4. BUNNEY MH: Viral Warts: Their Biology and Treatment, p 1, Oxford University Press, New York, 1982.
5. JOHNSON LW: Communal showers and the risk of plantar warts. J Fam Pract 40: 136, 1995.
6. SMOTKIN D: Virology of human papillomavirus. Clin Obstet Gynecol 32: 117, 1989.
7. SHELLEY WB, SHELLEY ED: Intralesional bleomycin sulfate therapy for warts: a novel bifurcated needle puncture technique. Arch Dermatol 127: 234, 1991.
8. LASSER AE, GLAZER SD: Vehicle effects on comparative irritancy: a patient compliance in topical wart therapy. Curr Ther Res 39: 1011, 1986.
9. FABBROCINI G, DI COSTANZO MP, RICCARDO AM, ET AL: Photodynamic therapy with topical delta-aminolaevulinic acid for the treatment of plantar warts. J Photochem Photobiol B 61: 30, 2001.
10. BUCKLEY D: Cryosurgery treatment of plantar warts. Ir Med J 93: 140, 2000.
11. EL-TONSY MH, ANBAR TE, EL-DOMYATI M, ET AL: Density of viral particles in pre and post Nd: YAG laser hyperthermia therapy and cryotherapy in plantar warts. Int J Dermatol 38: 393, 1999.
12. POLLOCK B, SHEEHAN-DARE R: Pulsed dye laser and intralesional bleomycin for treatment of resistant viol hand warts. Lasers Surg Med 30: 135, 2002.
13. MANZ LA, PELACHYK JM: Bleomycin-lidocaine mixture reduces pain of intralesional injection in the treatment of recalcitrant verrucae. J Am Acad Dermatol 25: 524, 1991.
14. UMEZAWA H: Chemistry and mechanism of action of bleomycin. Fed Proc 33: 2296, 1974.
15. TEMPLETON SF, SOLOMON AR, SWERLICK RA: Intradermal bleomycin injections into normal human skin. Arch Dermatol 130: 577, 1994.
16. UMEZAWA H, MAEDA K, TAKEUCHI T, ET AL: New antibiotics, bleomycin A and B. J Antibiot A 19: 200, 1966.
17. SHUMER SM, O'KEEFE EJ: Bleomycin in the treatment of recalcitrant warts. J Am Acad Dermatol 9: 91, 1983.
18. ICHIKAWA T, NAKANO I, HIROKAWA I: Bleomycin treatment of the tumors of penis and scrotum. J Urol 102: 699, 1969.
19. YAGODA A, MUKHERJI B, YOUNG C, ET AL: Bleomycin, an antitumor antibiotic. Ann Intern Med 77: 861, 1972.
20. JAMES MP, COLLIER PM, AHERNE W, ET AL: Histologic, pharmacologic, and immunocytochemical effects of injection of bleomycin into viral warts. J Am Acad Dermatol 28: 933, 1993.
21. CROOKE ST, BRADNER WT: Bleomycin: a review. J Med 7: 333, 1977.
22. KUO MT, HAIDLE CW: Characterization of chain break-age in DNA induced by bleomycin. Biochim Biopys Acta 335: 109, 1974.
23. BENNETT JM, REICH SD: Bleomycin. Ann Intern Med 90: 945, 1979.
24. CORDEKO AA, GUGLIELMI HA, WOSCOFF A: The common wart: intralesional treatment with bleomycin sulfate. Cutis 26: 319, 1980.
25. OLSON RL: Plantar warts yield to DNA inhibitor. JAMA 237: 940, 1977.
26. MIDDLETON RK, CHAN S: Bleomycin treatment of warts. DICP 24: 952, 1990.
27. MILLER R: Nail dystrophy following intralesional injections of bleomycin for a periungual wart [letter]. Arch Dermatol 120: 963, 1984.
28. SOLLITTO RJ, PIZZANO DM: Bleomycin sulfate in the treatment of mosaic plantar verrucae: a follow-up study. J Foot Ankle Surg 35: 169, 1996.
29. ABBOTT LG: Treatment of warts with bleomycin. Aust J Dermatol 19: 67, 1978.
30. AMER M, DIAB N, RAMADAN A, ET AL: Therapeutic evaluation for intralesional injection of bleomycin sulfate in 143 resistant warts. J Am Acad Dermatol 18: 1313, 1988.
31. HALL SW, BROUGHTON A, STRONG JE, ET AL: Clinical pharmacology of bleomycin by radio-immunoassay. Clin Res 25: 407, 1977.
32. CARTER ST, CROOKE ST, UMEZAWA H (EDS): Bleomycin: Current Status and New Developments, Academic Press, New York, 1978.
33. LE BOUFFANT R, CORMIER P, MULNER-LORILLON O, ET AL: Hypoxia and DNA-damaging agent bleomycin both increase the cellular level of the protein 4E-BP. J Cell Biochem [e-pub], April 5, 2006.
34. MEBERG R, KENYON E, BIERMAN R, ET AL: Characterization of plantar verrucae among individuals with human immunodeficiency virus. JAPMA 88: 442, 1998.
35. KANG S, FITZPATRICK T: Debilitating verruca vulgaris in a patient infected with the human immunodeficiency virus. Arch Dermatol 130: 294, 1994.
36. BARBOSA P: Plantar verrucae and HIV infection. Clin Podiatr Med Surg 15: 317, 1998.
37. MEMAR O, CIRELLI R, LEE P, ET AL: Cutaneous manifestations of HIV-1 infection. JAPMA 85: 362, 1995.